Caliper Q2 Revenues Bounce 32 Percent on Strong Research Business | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Driven by its Research business, Califer Life Sciences reported after the close of the market on Tuesday a 32 percent year-over-year increase in revenues for the second quarter.

For the three months ended June 30, total revenues climbed to $38.3 million, up from $29.1 million a year ago. Organically, revenues grew 23 percent year over year, the company said.

Wall Street had expected $34.4 million in total revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.